EP1784499A4 - Biomarkers for bladder cancer - Google Patents

Biomarkers for bladder cancer

Info

Publication number
EP1784499A4
EP1784499A4 EP05804464A EP05804464A EP1784499A4 EP 1784499 A4 EP1784499 A4 EP 1784499A4 EP 05804464 A EP05804464 A EP 05804464A EP 05804464 A EP05804464 A EP 05804464A EP 1784499 A4 EP1784499 A4 EP 1784499A4
Authority
EP
European Patent Office
Prior art keywords
biomarkers
bladder cancer
bladder
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05804464A
Other languages
German (de)
French (fr)
Other versions
EP1784499A2 (en
Inventor
Antonia Vlahou
O John Semmes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eastern Virginia Medical School
Original Assignee
Eastern Virginia Medical School
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eastern Virginia Medical School filed Critical Eastern Virginia Medical School
Publication of EP1784499A2 publication Critical patent/EP1784499A2/en
Publication of EP1784499A4 publication Critical patent/EP1784499A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
EP05804464A 2004-07-23 2005-07-20 Biomarkers for bladder cancer Withdrawn EP1784499A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59035004P 2004-07-23 2004-07-23
PCT/US2005/025632 WO2006020302A2 (en) 2004-07-23 2005-07-20 Biomarkers for bladder cancer

Publications (2)

Publication Number Publication Date
EP1784499A2 EP1784499A2 (en) 2007-05-16
EP1784499A4 true EP1784499A4 (en) 2007-08-22

Family

ID=35908003

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05804464A Withdrawn EP1784499A4 (en) 2004-07-23 2005-07-20 Biomarkers for bladder cancer

Country Status (4)

Country Link
EP (1) EP1784499A4 (en)
AU (1) AU2005274726A1 (en)
CA (1) CA2574831A1 (en)
WO (1) WO2006020302A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1775590A1 (en) * 2005-10-11 2007-04-18 Laboratorios S.A.L.V.A.T., S.A. Non-invasive in vitro method to detect transitional cell carcinoma of the bladder
US8983580B2 (en) 2008-01-18 2015-03-17 The Board Of Trustees Of The University Of Illinois Low-coherence interferometry and optical coherence tomography for image-guided surgical treatment of solid tumors
US8945511B2 (en) 2009-06-25 2015-02-03 Paul Weinberger Sensitive methods for detecting the presence of cancer associated with the over-expression of galectin-3 using biomarkers derived from galectin-3
EP2602621A1 (en) 2011-12-08 2013-06-12 Julius-Maximilians-Universität Würzburg LASP-1, a novel urinary marker for transitional cell carcinoma detection

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002027329A2 (en) * 2000-09-25 2002-04-04 Eastern Virginia Medical School Biomarkers of transitional cell carcinoma of the bladder
WO2003072710A2 (en) * 2002-02-21 2003-09-04 Eastern Virginia Medical School Protein biomarkers that distinguish prostate cancer from non-malignant cells
WO2003091695A2 (en) * 2002-04-26 2003-11-06 The Johns Hopkins University Identification of biomarkers for detecting prostate cancer

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002027329A2 (en) * 2000-09-25 2002-04-04 Eastern Virginia Medical School Biomarkers of transitional cell carcinoma of the bladder
WO2003072710A2 (en) * 2002-02-21 2003-09-04 Eastern Virginia Medical School Protein biomarkers that distinguish prostate cancer from non-malignant cells
WO2003091695A2 (en) * 2002-04-26 2003-11-06 The Johns Hopkins University Identification of biomarkers for detecting prostate cancer

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CELIS JULIO E ET AL: "A comprehensive protein ressource for the study of bladder cancer: http://biobase.dk/cgi-bin/celis", ELECTROPHORESIS, vol. 20, no. 2, February 1999 (1999-02-01), pages 300 - 309, XP002440996, ISSN: 0173-0835 *
VLAHOU ANTONIA ET AL: "Application of a novel protein chip mass spectrometry technology for the identification of bladder cancer-associated biomarkers.", ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY 2003, vol. 539, no. Pt A, 2003, pages 47 - 60, XP009086225, ISSN: 0065-2598 *
ZHANG Y-F ET AL: "Tree analysis of mass spectral urine profiles discriminates transitional cell carcinoma of the bladder from noncancer patient", CLINICAL BIOCHEMISTRY, PERGAMON PRESS, vol. 37, no. 9, September 2004 (2004-09-01), pages 772 - 779, XP004536377, ISSN: 0009-9120 *

Also Published As

Publication number Publication date
WO2006020302A2 (en) 2006-02-23
EP1784499A2 (en) 2007-05-16
WO2006020302A3 (en) 2006-06-08
CA2574831A1 (en) 2006-02-23
AU2005274726A1 (en) 2006-02-23

Similar Documents

Publication Publication Date Title
EP1756566A4 (en) Biomarkers for ovarian cancer
EP1778856A4 (en) Platelet biomarkers for cancer
GB0719792D0 (en) Cancer biomarkers
EP1735620A4 (en) Lung cancer biomarkers
EP1934603A4 (en) Biomarker for prostate cancer
EP1910821A4 (en) Biomarkers for ovarian cancer
EP1802764A4 (en) Biomarkers for breast cancer
HK1077583A1 (en) Cudr as biomarker for cancer progression and therapeutic response
EP1831694A4 (en) Eph receptor tumor biomarkers
PL1720611T3 (en) Diagnostic marker for cancer
IL186351A0 (en) Mobile location
EP2061899A4 (en) Biomarkers for prostate cancer and methods using the same
IL179891A0 (en) Tumor specific antibody
EP1664716A4 (en) Biomarkers in cancer
EP1907857A4 (en) Biomarkers for breast cancer
PT1830847E (en) Treatment for cancer
HK1108924A1 (en) Cancer prognostic methods
GB0421838D0 (en) Cancer markers
GB0511302D0 (en) Biomarkers
EP1784499A4 (en) Biomarkers for bladder cancer
GB0401876D0 (en) New use for cancer antigen
EP1934825A4 (en) Mobile sitemaps
HU0400305D0 (en) Set for spine-fixture
IL163564A0 (en) Floating preiscope
ZA200709016B (en) Mobile location

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20070222

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

RIC1 Information provided on ipc code assigned before grant

Ipc: G01N 33/537 20060101ALI20070712BHEP

Ipc: G01N 33/574 20060101AFI20070712BHEP

Ipc: G01N 33/68 20060101ALI20070712BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20070723

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1100783

Country of ref document: HK

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20071102

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20090609

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1100783

Country of ref document: HK